BioLife Solutions (BLFS) Tops Q4 EPS by 23c ; Offers Guidance

BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of $0.22, $0.23 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $24.8 million versus the consensus estimate of $24.05 million.

GUIDANCE:

BioLife Solutions sees FY2026 revenue of $112.5-115 million, versus the consensus of $110.8 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.

You May Also Be Interested In

• Trump on war in Ukraine: Putin does feel pressure, end closer than people realize
• Increasing unusual option volume: PEW SOLS PEG VAL DOMO JACK UNM OCUL HDB
• Market Vectors Semiconductor ETF (SMH) call put ratio 1 call to 5.9 puts with a focus on 40K contracts of July 540 puts as share up 2.9%